$2.5 mn funding garnered by NirogStreet from Pureland Venture, others
Thu, Jul 22, 2021 2:23 PM

$2.5 mn funding garnered by NirogStreet from Pureland Venture, others

Get it on Google Play
NirogStreet raised $2.5 Mn in Series A Funding. The funding was secured from Gokul Rajaram of Pureland Venture, Raj Mishra of Indea Capital, former CEO of Morgan Stanley Ashutosh Sinha, and founder of Livspace Anuj Srivastava among others. The Ayurveda Doctor platform will deploy the funds towards strengthening technology offering for the doctors and starting operations in more states.

More great flips

Freightify announces $2.5 million in pre-Series A round

Freightify announces $2.5 million in pre-Series A round

Freightify, on Tuesday, bagged $2.5 million funding in pre-Series A round led by Nordic Eye Venture Capital, with the participation of Tradeworks VC, Venture Catalysts, 9Unicorns, Blume Founders Fund, and existing investor Vinod Kumar Talreja. Freightify features a suite of pricing and sales tools for the ocean freight industry and already serves customers in more than 10 countries.

Open Flip
Alankit becomes a Service Provider for processing Ayushman Bharat Cards

Alankit becomes a Service Provider for processing Ayushman Bharat Cards

Alankit Limited has been empanelled as Service Provider for processing of Ayushman Bharat Card Request with National Health Authority, Ministry of Health & Family Welfare. Alankit is an India-based firm concerned with the e-governance business and the sale of e-governance products. The Company operates through two business segments: E-Governance and Financial Activities.

Open Flip
GlaxoSmithKline Pharmaceuticals registers PAT of Rs 121 crore in Q1'FY22

GlaxoSmithKline Pharmaceuticals registers PAT of Rs 121 crore in Q1'FY22

GlaxoSmithKline Pharmaceuticals announced a consolidated net profit of Rs121.08cr up by 9.2% on a 21.8% increase in net sales to Rs789.99cr for Q1FY22 compared to a year ago same period. The drugmaker even confirmed its decision to transfer its rights about the /odex and Ostoca/cium brands to GlaxoSmithKline Asia Private Limited for a consideration of Rs1649cr.

Open Flip

Join our Smart Investment Community

More than 250,000 users are using FlipItNews to stay updated about the business and finance world! Join FlipItNews now and take smart investment decisions!
Icon